Patent intelligence · US
US 8772258
Single walled carbon nanotube/sirna complexes and methods related thereto
Single walled carbon nanotube/sirna complexes and methods related thereto
Patent details — US 8772258
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 8, 2014
- Expiration
- Jul 3, 2034
- Applicant
- Ensysce Biosciences Inc.
- Claims
- 12
- CPC classes
- A61K, A61K47/6925, A61K9/0019, A61K9/0092
Quick answer
US 8772258 (Single walled carbon nanotube/sirna complexes and methods related thereto) is held by Ensysce Biosciences Inc.. Status: granted. Granted Jul 8, 2014. Expires Jul 3, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Ensysce Biosciences Inc.
- Grant date
- Expiration
- Claims
- 12
- CPC classes
- A61K, A61K47/6925, A61K9/0019, A61K9/0092, A61P, A61P35/00
More from Ensysce Biosciences Inc.
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 8772258?
US 8772258 (Single walled carbon nanotube/sirna complexes and methods related thereto) is held by Ensysce Biosciences Inc.. Status: granted. Granted Jul 8, 2014. Expires Jul 3, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8772258?
Ensysce Biosciences Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 2 pharmaceutical patents for this assignee.
When does US 8772258 expire?
Our index shows an expiration date of Jul 3, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.